AtriCure (ATRC) Long-Term Investments (2011 - 2023)

AtriCure (ATRC) has 11 years of Long-Term Investments data on file, last reported at $7.6 million in Q2 2023.

• On a quarterly basis, Long-Term Investments fell 88.18% year-over-year to $7.6 million in Q2 2023; TTM through Jun 2023 was $7.6 million, a 88.18% decrease from a year earlier, with the FY2022 full-year figure at $51.5 million, down 50.63% from the prior year.
• Long-Term Investments for Q2 2023 stood at $7.6 million, down from $25.6 million in the prior quarter.
• Over the last five years, Long-Term Investments for ATRC reached as high as $105.1 million in Q3 2021 and fell as low as $7.6 million in Q2 2023.
• Historically, Long-Term Investments has averaged $40.7 million across 5 years, with a median of $23.0 million in 2019.
• Across the five-year window, Long-Term Investments surged 672.59% in 2022 and slumped 88.18% in 2023, its largest moves.
• Year by year, Long-Term Investments stood at $12.7 million in 2019, then grew by 11.86% to $14.2 million in 2020, then jumped by 635.91% to $104.3 million in 2021, then plunged by 50.63% to $51.5 million in 2022, then sank by 85.25% to $7.6 million in 2023.
• Per Business Quant data, the three most recent Long-Term Investments figures were $7.6 million in Q2 2023, $25.6 million in Q1 2023, and $51.5 million in Q4 2022.